Leri pleonosteosis

From WikiMD's WELLNESSPEDIA


Léri pleonosteosis
Synonyms Léri's disease, Léri's syndrome
Pronounce N/A
Specialty N/A
Symptoms Joint contractures, thickened skin, broad thumbs, short stature
Complications Arthritis, limited mobility
Onset Childhood
Duration Lifelong
Types N/A
Causes Genetic mutation
Risks Family history
Diagnosis Clinical examination, genetic testing
Differential diagnosis Scleroderma, Marfan syndrome, Ehlers-Danlos syndrome
Prevention N/A
Treatment Physical therapy, surgery
Medication Pain management
Prognosis Variable
Frequency Rare
Deaths N/A


Leri pleonosteosis is a rare autosomal dominant genetic disorder that affects the skeletal system. It is characterized by unusual facial features, limited joint mobility, and short stature. The condition was first described by André Léri and J. Pleon in 1929.

Symptoms and Signs[edit]

The most common symptoms of Leri pleonosteosis include short stature, limited joint mobility, and unusual facial features. These facial features often include a broad nose, wide mouth, and thick lips. Other symptoms can include camptodactyly (permanent bending of the fingers or toes), brachydactyly (short fingers or toes), and syndactyly (webbed or fused fingers or toes).

Causes[edit]

Leri pleonosteosis is caused by mutations in the FLNB gene. This gene provides instructions for making a protein called filamin B, which helps build the network of protein filaments that gives structure to cells and allows them to change shape and move. Mutations in the FLNB gene disrupt the normal development of bones and other tissues, leading to the features of Leri pleonosteosis.

Diagnosis[edit]

Diagnosis of Leri pleonosteosis is based on physical examination and the presence of characteristic symptoms. Genetic testing can confirm the diagnosis by identifying a mutation in the FLNB gene.

Treatment[edit]

There is currently no cure for Leri pleonosteosis. Treatment is symptomatic and supportive, and may include physical therapy to improve joint mobility, and surgery to correct bone abnormalities.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.